These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17024549)

  • 21. Extrapyramidal symptoms during treatment of first schizophrenia episode: results from EUFEST.
    Rybakowski JK; Vansteelandt K; Remlinger-Molenda A; Fleischhacker WW; Kahn RS; Peuskens J;
    Eur Neuropsychopharmacol; 2014 Sep; 24(9):1500-5. PubMed ID: 25085534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. National prescribing patterns in the management of extrapyramidal symptoms among patients with schizophrenia.
    Luo RD; Belleti DA; Tran D; Arcona S; Salen PN
    Int J Psychiatry Med; 2002; 32(3):261-9. PubMed ID: 12489701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroleptic-induced extrapyramidal symptoms and serum calcium levels. Results of a pilot study.
    Kuny S; Binswanger U
    Neuropsychobiology; 1989; 21(2):67-70. PubMed ID: 2575718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine.
    Schillevoort I; de Boer A; Herings RM; Roos RA; Jansen PA; Leufkens HG
    Ann Pharmacother; 2001 Dec; 35(12):1517-22. PubMed ID: 11793611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Life-threatening dysphagia following prolonged neuroleptic therapy.
    Hayashi T; Nishikawa T; Koga I; Uchida Y; Yamawaki S
    Clin Neuropharmacol; 1997 Feb; 20(1):77-81. PubMed ID: 9037576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYP2D6 *6/*6 genotype and drug interactions as cause of haloperidol-induced extrapyramidal symptoms.
    Šimić I; Potočnjak I; Kraljičković I; Stanić Benić M; Čegec I; Juričić Nahal D; Ganoci L; Božina N
    Pharmacogenomics; 2016 Aug; 17(13):1385-9. PubMed ID: 27469576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trial.
    Wynchank D; Berk M
    Hum Psychopharmacol; 2003 Jun; 18(4):271-5. PubMed ID: 12766931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks.
    Kane JM; Crandall DT; Marcus RN; Eudicone J; Pikalov A; Carson WH; Swyzen W
    Schizophr Res; 2007 Sep; 95(1-3):143-50. PubMed ID: 17644313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review and Bayesian meta-analysis of clinical efficacy and adverse effects of 4 atypical neuroleptic drugs compared with haloperidol and placebo.
    Klemp M; Tvete IF; Skomedal T; Gaasemyr J; Natvig B; Aursnes I
    J Clin Psychopharmacol; 2011 Dec; 31(6):698-704. PubMed ID: 22020356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extrapyramidal side effects in patients with Alzheimer's disease treated with low-dose neuroleptic medication.
    Caligiuri MP; Rockwell E; Jeste DV
    Am J Geriatr Psychiatry; 1998; 6(1):75-82. PubMed ID: 9469217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
    Honer WG; Kopala LC; Rabinowitz J
    J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol.
    Zivković M; Mihaljević-Peles A; Bozina N; Sagud M; Nikolac-Perkovic M; Vuksan-Cusa B; Muck-Seler D
    J Clin Psychopharmacol; 2013 Oct; 33(5):593-9. PubMed ID: 23963056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA; Brecher M; Paulsson B
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysphagia associated with risperidone therapy.
    Stewart JT
    Dysphagia; 2003; 18(4):274-5. PubMed ID: 14571332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Progressive dysphagia with peculiar laryngeal movement induced by tardive dystonia].
    Aino I; Saigusa H; Nakamura T; Matsuoka C; Komachi T; Kokawa T
    Nihon Jibiinkoka Gakkai Kaiho; 2006 Nov; 109(11):785-8. PubMed ID: 17165593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The assessment of neuroleptogenic extrapyramidal syndroms in psychopharmacological research (author's transl)].
    Mattke DJ; Mombour W; Glötzner FL
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Jan; 8(1):36-44. PubMed ID: 788001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meige's syndrome associated with neuroleptic treatment.
    Ananth J; Edelmuth E; Dargan B
    Am J Psychiatry; 1988 Apr; 145(4):513-5. PubMed ID: 2894781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
    Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB
    Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.